Citeline

Citeline

Immuno-Oncology (IO) in Non-Small Cell Lung Cancer (NSCLC)

By Doro Shin 23 Nov 2018

A clinical review of the competitive landscape, approved therapies, trial outcomes and experienced investigators in this highly targeted space.

Citeline, Citeline Analytics

2017 Completed Clinical Trials: Status Quo or No Webinar Recording

By Laura Runkel 08 Nov 2018

For a deeper look into the data behind last year’s completed clinical trials and the trends driving them, Listen to the Completed Clinical Trials 2017: Status Quo or No?

Citeline

Depression New Insights Shifting the Treatment Paradigm Whitepaper

By Pippa Nutkins 05 Nov 2018

Depression affects approximately 1 in 6 Americans, with 10 – 30% of depression patients becoming treatment-resistant. Find out what the pipeline looks like for depression and what the emerging strategies in this area are. This data-packed whitepaper from Informa Pharma Intelligence can now be downloaded – free.

Citeline, Trialtrove

Rheumatoid Arthritis - Old and New Approaches Shifting the Treatment Paradigm

By Laura Runkel 19 Oct 2018

Explore the current and future outlook for rheumatoid arthritis (RA) treatments. Such treatments remain ineffective for the 33% of RA sufferers who are or become unresponsive to treatment, resulting in a high interest in RA drug development to address this unmet need in the marketplace.

Citeline

Clinical Trials Industry Report

By KNect365 28 Aug 2018

Clinical trials are continually evolving, particularly in light of increasing pressures from new technologies and other disruptors. Trends ranging from artificial intelligence (AI) and mHealth to patient-centricity are challenging the industry to innovate against the backdrop of looming regulatory changes and shifting competitor landscapes resulting from M&A activity. In order to explore these trends, KNect365 Life Sciences recently conducted one of the biggest surveys of its kind across clinical trial professionals from within pharma, CROs, sites, service providers, academia and patient groups across the world to look beyond the hype.

Citeline

2017 Completed Clinical Trials: Disease and Sponsor Assessment in 9 Key Tables

02 Aug 2018

Citeline’s completed clinical trial landscape provides a more granular view of how companies are progressing their pipelines and the disease strategies they are pursuing, compared to static pipeline snapshots.

Citeline, Scrip, Biomedtracker, Datamonitor Healthcare

ASCO Essentials Webinar 2018 Recording

By Mary Jo Laffler 29 May 2018

Just in time for your 2018 ASCO Annual Meeting planning, join analysts from Datamonitor Healthcare, Biomedtracker, Citeline, Scrip, and Pink Sheet for their expert opinions on what you need to know to get the most from the meeting. Let our experts present their top picks from the thousands of abstracts being presented at ASCO.

Citeline

Webinar recording: Partnering shared expertise and technology to optimize study planning

By Loni Branon 24 May 2018

The 9th Annual SCOPE (Summit for Clinical Trials Operations Executives) Summit has concluded: join industry expert and clinical trial planning thought leader Loni Branon as she hosts a follow-up to this important annual event, where Informa Pharma Intelligence hosted a launch party for our exciting new Citeline platform.

Pharmaprojects, Citeline

Pharma R&D Annual Review 2018

By Ian Lloyd 15 May 2018

Authored for the last 25 years by Ian Lloyd, Senior Director of Pharmaprojects and Data Integration, this vital resource uses a music motif to turn up the volume on the evolution of trends in pharmaceutical R&D. Lloyd assesses industry trends by examining the pipeline by company, therapeutic area, disease, target, and drug type.

Citeline

Industry celebrates at Informa Pharma Intelligence's 3rd Annual CARE Awards

By Doro Shin 15 May 2018

The CARE Awards ceremony was held on April 25th at the Boston Harbor Hotel to pay tribute to the people driving the advances in drug development and their commitments to advancing human health. The ceremony was once again hosted by multi-media journalist, Janet Wu, former Anchor and Health Reporter for Boston’s NBC station and adjunct professor at Emerson College

Citeline

2016 Completed Clinical Trials: Industry Strategies Revealed and Graded Webinar Recording

17 Jul 2017

Using exclusive data from Citeline’s Trialtrove, part of the Informa Pharma Intelligence suite of tools, our analysts will go beyond the numbers and dig into the granular details and their implications.

Citeline

Citeline’s Trialtrove and Sitetrove: New Platform

29 Jun 2017

We've made the valuable and trustworthy content of Sitetrove and Trialtrove even better via the enhanced features of the new platform.

Citeline

Multiple Sclerosis Landscape: Is there a paradigm shift?

By Christine Blazynski 01 Jun 2017

The standard of care treatment for multiple sclerosis involves immunomodulatory therapy  to relieve and/or modify symptoms; the vast majority of these are large biologic molecules and are administered via injection. 

Citeline

Rising to the Challenge: An Analysis of the Influenza Vaccine Landscape in Response to the Swine Flu Pandemic

By Gabrielle Gessner 07 Oct 2013

The swine influenza pandemic in 2009/10 highlighted numerous challenges in providing effective influenza vaccine coverage.

Citeline

Using Clinical Trials Activity to Assess Competitor Strategies

By Tracy DeGregorio 01 Oct 2012